个性化文献订阅>文章检索
  文章名  
  作者  
  期刊名  
  摘要  
   
   
   
  如果没有找到您所需要的文献,请点击 ——此处申请  
  共15条记录  
  • Placebo-Controlled Trial of Amantadine for Severe Traumatic Brain Injury
    [作者:Giacino, JT; Whyte, J; Bagiella, E; Kalmar, K; Childs, N; Khademi, A; Eifert, B; Long, D; Katz, DI; Cho, S; Yablon, SA; Luther, M; Hammond, FM; Nordenbo, A; Novak, P; Mercer, W; Maurer-Karattup, P; Sherer, M,期刊:New England Journal of Medicine, 页码:819-826 , 文章类型: Article,,卷期:2012年366-9]
  • BACKGROUND Amantadine hydrochloride is one of the most commonly prescribed medications for patients with prolonged disorders of consciousness after traumatic brain injury. Preliminary studies have suggested that amantadi...
  • A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
    [作者:Verstovsek, S; Mesa, RA; Gotlib, J; Levy, RS; Gupta, V; DiPersio, JF; Catalano, JV; Deininger, M; Miller, C; Silver, RT; Talpaz, M; Winton, EF; Harvey, JH; Arcasoy, MO; Hexner, E; Lyons, RM; Paquette, R; Raza, A; Vaddi, K; Erickson-Viitanen, S; Koumenis, IL; Sun, W; Sandor, V; Kantarjian, HM,期刊:New England Journal of Medicine, 页码:799-807 , 文章类型: Article,,卷期:2012年366-9]
  • BACKGROUND Ruxolitinib, a selective inhibitor of Janus kinase (JAK) 1 and 2, has clinically significant activity in myelofibrosis. METHODS In this double-blind trial, we randomly assigned patients with intermediate-2 or ...
  • A Startling Decline
    [作者:Rinne, ML; McGinnis, SM; Samuels, MA; Katz, JT; Loscalzo, J,期刊:New England Journal of Medicine, 页码:836-842 , 文章类型: Article,,卷期:2012年366-9]
  • An 89-year-old man was brought to the emergency department by his wife and son for an evaluation of changes in cognition and personality. Six months earlier, he began to require help managing finances and operating his c...